Octapharma Plasma, Inc.
Octapharma Plasma, Inc., a leading player in the biopharmaceutical industry, is headquartered in the United States and operates numerous plasma donation centres across the country. Founded in 1983, Octapharma has established itself as a key provider of human protein therapies, focusing on the development and production of high-quality plasma-derived products. The company’s core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. Octapharma's commitment to innovation and quality has positioned it as a trusted name in the market, with notable achievements in expanding its operational footprint and enhancing patient care. With a strong emphasis on safety and efficacy, Octapharma Plasma continues to play a vital role in the healthcare landscape, making significant contributions to the treatment of patients worldwide.
DitchCarbon Score
How does Octapharma Plasma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Octapharma Plasma, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Octapharma Plasma, Inc.'s reported carbon emissions
Octapharma Plasma, Inc., headquartered in the US, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that Octapharma Plasma, Inc. has not outlined any specific reduction targets or climate commitments. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the industry increasingly prioritises sustainability and carbon footprint reduction, it will be essential for Octapharma Plasma, Inc. to establish clear climate commitments and reduction targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Octapharma Plasma, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
